Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (281-290 of 501) with videos related to

Pageof 51
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse ratesRyotaro Nakamura, Nademanee Auayporn, David D Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
JACC. Cardiooncology|August 24, 2023
Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation RecipientsRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Blood|December 8, 2009
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimensRoberto Rodriguez, Ryotaro Nakamura, Joycelynne M Palmer, et al.
Cancer Research Communications|March 27, 2023
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T CellsRenate Starr, Brenda Aguilar, Diana Gumber, et al.
Molecular Therapy. Oncology|June 28, 2024
Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cellsKelly T Kennewick, Yukiko Yamaguchi, Jackson Gibson, et al.
Blood|May 29, 2010
Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter studyJan W Gratama, Michael Boeckh, Ryotaro Nakamura, et al.
Transplantation and Cellular Therapy|June 21, 2021
Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Survivor Study ReportSmith Giri, Yanjun Chen, Jessica Wu, et al.
Journal of the National Cancer Institute|April 6, 2019
Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell TransplantationSaro H Armenian, Meisi Xiao, Jennifer Berano Teh, et al.
Leukemia|April 5, 2024
Pre-frailty after blood or marrow transplantation and the risk of subsequent mortalityNora Balas, Joshua S Richman, Wendy Landier, et al.
Pageof 51

Showing results (281-290 of 501) with videos related to

Sort By:
Pageof 51
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse ratesRyotaro Nakamura, Nademanee Auayporn, David D Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
JACC. Cardiooncology|August 24, 2023
Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation RecipientsRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Blood|December 8, 2009
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimensRoberto Rodriguez, Ryotaro Nakamura, Joycelynne M Palmer, et al.
Cancer Research Communications|March 27, 2023
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T CellsRenate Starr, Brenda Aguilar, Diana Gumber, et al.
Molecular Therapy. Oncology|June 28, 2024
Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cellsKelly T Kennewick, Yukiko Yamaguchi, Jackson Gibson, et al.
Blood|May 29, 2010
Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter studyJan W Gratama, Michael Boeckh, Ryotaro Nakamura, et al.
Transplantation and Cellular Therapy|June 21, 2021
Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Survivor Study ReportSmith Giri, Yanjun Chen, Jessica Wu, et al.
Journal of the National Cancer Institute|April 6, 2019
Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell TransplantationSaro H Armenian, Meisi Xiao, Jennifer Berano Teh, et al.
Leukemia|April 5, 2024
Pre-frailty after blood or marrow transplantation and the risk of subsequent mortalityNora Balas, Joshua S Richman, Wendy Landier, et al.
Pageof 51